- My Forums
- Tiger Rant
- LSU Recruiting
- SEC Rant
- Saints Talk
- Pelicans Talk
- More Sports Board
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Show Left Links
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Started By
Message
re: AUPH - Aurinia Pharmaceuticals [CEO FIRED!]
Posted on 11/7/25 at 10:02 am to Chucktown_Badger
Posted on 11/7/25 at 10:02 am to Chucktown_Badger
Good for those still in, on the aurina
Few guys I work with still have it. I needed th cash, and made some coin.
Few guys I work with still have it. I needed th cash, and made some coin.
Posted on 11/7/25 at 11:19 am to Chucktown_Badger
Haha same for me. I think I had 300 shares and I dumped them the moment I hit the black. I'm so glad to be off this ride.
Posted on 11/7/25 at 11:49 am to BRPelican45
My story is different. I bought my first shares at 2.65 in 2017. Have been buying and selling shares, CC's and puts since. I am down to just 500 shares with CC's on most at 15. Want to sell to move into other investments. I am up more than 20K in 8 1/2 years. Ready to move on now.
Posted on 3/23/26 at 8:17 am to jerryc436
Value destroying CEO finally canned after seven long years.
quote:
ROCKVILLE, Maryland & EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) announced today that Kevin Tang, Aurinia’s Chair of the Board, will succeed Peter Greenleaf as Chief Executive Officer. Peter will continue as a consultant to facilitate the transition.
“Aurinia thanks Peter for his many contributions to the Company over his 7-year tenure and wishes him the best in his future endeavors,” stated Mr. Tang. “Aurinia today is in an extremely strong position in no small part due to Peter’s stewardship. LUPKYNIS is emerging as a standard therapy for lupus nephritis, and our lead pipeline product, aritinercept, is advancing quickly through clinical studies. I look forward to working closely with the Aurinia team on our quest to bring life-altering treatments to patients suffering from autoimmune diseases.”
Posted on 3/23/26 at 8:47 am to bayoubengals88
Had some more CC's assigned. Still have 200 shares and used my proceeds to invest in HGRAF and NBIS.
Popular
Back to top

0





